+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 38 Pages
  • December 2021
  • Region: Global
  • GlobalData
  • ID: 5517708
the publisher's Medical Devices sector report, “Troponin Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Troponin Rapid Tests & Point of Care (POC) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Troponin Rapid Tests & POC are point-of-care diagnostic tests enables to measure troponin levels specific to cardiovascular diseases in patient’s sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Troponin Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Troponin Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Troponin Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Troponin Rapid Tests & POC Overview
3 Products under Development
3.1 Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Troponin Rapid Tests & POC - Pipeline Products by Territory
3.3 Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date
4 Troponin Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Troponin Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
5 Troponin Rapid Tests & POC Companies and Product Overview
6 Troponin Rapid Tests & POC- Recent Developments
6.1 Sep 01, 2021: BioMerieux announce First-Half 2021 Results
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
  • Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
  • Troponin Rapid Tests & POC - Pipeline Products by Territory
  • Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date
  • Troponin Rapid Tests & POC Companies - Pipeline Products by Stage of Development
  • Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
  • Glossary

List of Figures
  • Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
  • Troponin Rapid Tests & POC - Pipeline Products by Territory
  • Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
  • Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Point of Care Inc
  • Angle Biosciences Inc
  • Anteo Technologies Pty Ltd
  • BBB Technologies Inc
  • Bio-AMD Inc
  • Bluejay Diagnostics Inc
  • Carclo Diagnostic Solutions Ltd
  • Group K Diagnostics
  • LumiraDx Ltd
  • MML Ltd
  • Nanomix Inc
  • Ohmx Corp
  • OPKO Health Inc
  • Proxim Diagnostics Corp
  • Resdin Technologies Inc.
  • Sandia National Laboratories
  • SpinChip Diagnostics AS